ruxolitinib 1.5% topical
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ruxolitinib 1.5% topical, covering 2026-04-28 to 2026-04-28. Get the full timeline:
Most recent: Clinical Trial Results: Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment [Phase 2]